MPS Pharma Ltd

NSE: ADVIKLA · BSE: 531686 · Pharmaceuticals & Biotechnology · 17 announcements

Share price

₹2.08

Market cap

₹3.98 Cr

Revenue (annual)

₹0.00 Cr

Net profit (annual)

₹-1.02 Cr

P/E (TTM)

-3.8×Sector 43.8×

Promoter holding

35.89%+0.00% QoQ

FII holding

0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.